According to a new market report published by Lucintel, the future of the oligonucleotide synthesis market looks promising with opportunities in research, diagnostic, and therapeutic applications. The global oligonucleotide synthesis market is expected to grow with a CAGR of 11% from 2020 to 2025. The major drivers for this market are rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.
To download report brochure, please go to https://www.lucintel.com/oligonucleotide-synthesis-market.aspx and click "download brochure" tab from the menu
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure. In this market, synthesized oligonucleotides, reagents & consumables, and equipment are the major offerings. Lucintel forecasts that synthesized oligonucleotides will remain the largest offering segment over the forecast period due to rising research and development activities related to oligonucleotide-based drugs.
Within this market, hospitals will remain the largest end user segment over the forecast period due to a significant number of inpatient and outpatient visits and increasing prevalance of cancer and infectious diseases.
North America will remain the largest region over the forecast period due to rising research and development activities related to life science and the increasing number of oligonucleotide-based drugs/therapies being approved by the FDA (Food and Drug Administration) in the region.
General Electric, Merck, Eurofins Scientific, Agilent Technologies, LGC Biosearch Technologies, Integrated DNA Technologies, GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec are among the major suppliers in the global oligonucleotide synthesis market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global oligonucleotide synthesis market by offering, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Oligonucleotide Synthesis Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global oligonucleotide synthesis market by offering, application, end user, and region as follows:
By Offering [Value ($ Million) shipment analysis for 2014 – 2025]:
Synthesized Oligonucleotides
Products
Oligonucleotide-Based Drugs
Primers
Probes
Large-Scale Synthesis Oligonucleotides
Intermediate-Scale Synthesis Oligonucleotides
Linkers & Adaptors
Services
Custom Oligonucleotides
Pre-Designed Oligonucleotides
Reagents & Consumables
Equipment
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Research
PCR (Polymerase Chain Reaction)
qPCR (Quantitative Polymerase Chain Reaction)
Sequencing
Gene Synthesis
Other Research Applications
Diagnostics
Therapeutics
DNA & Antisense Oligonucleotide-Based Therapies
RNAi Oligonucleotide-Based Therapies
CPG Oligonucleotide-Based Therapies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Hospitals
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.